Convalescent plasma may be a possible treatment for COVID-19: A systematic review.

ABSTRACT:

Introduction

The coronavirus disease 2019 (COVID-19) pandemic has spread globally. Therapeutic options including antivirals, anti-inflammatory compounds, and vaccines are still under study. Convalescent plasma(CP) immunotherapy was an effective method for fighting against similar viral infections such as SARS-CoV, and MERS-CoV. In the epidemic of COVID-19, a large number of literatures reported the application of CP. However, there is controversy over the efficacy of CP therapy for COVID-19. This systematic review was designed to evaluate the existing evidence and experience related to CP immunotherapy for COVID-19.

Methods

A literature search was conducted on Pubmed, Cochrane Library, Clinical Key, Wanfang Database; China National Knowledge Infrastructure(CNKI) were used to

SUBMITTER: Wang Y 

PROVIDER: S-EPMC7833727 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature